Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Eli Lilly and Company    LLY

ELI LILLY AND COMPANY

(LLY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Eli Lilly and Company
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:

- endocrinology (47.6%): products for treating osteoporosis, diabetes, and growth problems;

- oncology (17.4%);

- veterinary medicine (12.8%);

- cardiovascular diseases (9.2%);

- neurology (7.4%): primarily drugs used in treating depression and schizophrenia;

- immunology diseases (4.6%);

- other (1%).

Net sales are distributed geographically as follows: the United States (56.5%), Europe (17.2%), Japan (10.2%) and other (16.1%).

Number of employees : 38 680 people.
Sales per Businesses
20172018Delta
USD (in Million)%USD (in Million)%
Human Pharmaceutical Products19,78686.5%21,41387.2% +8.23%
Animal Health Products3,08613.5%3,14312.8% +1.84%
Sales per Regions
20172018Delta
USD (in Million)%USD (in Million)%
United States12,78555.9%13,87556.5% +8.53%
Europe3,94317.2%4,23117.2% +7.3%
Other Foreign Countries3,72316.3%3,95616.1% +6.24%
Japan2,42010.6%2,49410.2% +3.06%
Managers
NameAgeSinceTitle
David Ricks512017Chairman, President & Chief Executive Officer
Myles Oneill602018Senior VP & President-Manufacturing Operations
Joshua L. Smiley492018Chief Financial Officer & Senior Vice President
Timothy J. Garnett, Dr.-1998Chief Medical Officer & VP-Global Medical
Aarti S. Shah, Dr.542016Chief Information Officer & SVP-IT
Daniel M. Skovronsky, Dr.45-Chief Scientific Officer & Senior Vice President
Kathi P. Seifert691995Independent Director
Jon Erik Fyrwald602005Independent Director
Michael L. Eskew692008Independent Director
Ralph Alvarez632009Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Stock A 1 960,660,771 958,338,963 99.8% 530,000 0.1% 99.8%
Shareholders
NameEquities%
Lilly Endowment, Inc. 228,280,903 23.8%
Capital Research & Management Co. 109,033,091 11.4%
The Vanguard Group, Inc. 69,713,154 7.26%
PRIMECAP Management Co. 42,831,636 4.46%
Wellington Management Co. LLP 39,662,779 4.13%
SSgA Funds Management, Inc. 37,110,415 3.87%
Capital Research & Management Co. (International Investors) 25,145,261 2.62%
BlackRock Fund Advisors 21,334,727 2.22%
State Farm Investment Management Corp. 19,944,525 2.08%
Putnam LLC 15,502,039 1.61%
Holdings
NameEquities%Valuation
NextCure, Inc. (NXTC) 2,637,9469.62%148,595,498 USD
Dicerna Pharmaceuticals, Inc. (DRNA) 5,414,1857.91%119,274,496 USD
Zymeworks Inc. (ZYME) 1,545,5593.92%70,261,112 USD
Leap Therapeutics, Inc. (LPTX) 1,479,3076.11%1,656,824 USD
Markets and indexes
- NYSE
- Main Market
- SP 100 / SP 500, Stoxx Americas 100, Stoxx Global 200
Stock Exchange Codes
- Bloomberg Code :  LLY:US
- Reuters Code :  LLY.N
- Datastream Code :  
Company contact information
Eli Lilly and Company
Lilly Corporate Center
IN 46285 Indianapolis, Indiana
États-Unis (les)

Phone : +1 617-225-3226
Fax : +1
Internet : https://investor.lilly.com/
Brand Portfolio
In partnership withAllbrands.markets
More brands of Eli Lilly and Company
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
ELI LILLY AND COMPANY6.20%134 015
JOHNSON & JOHNSON2.26%392 596
ROCHE HOLDING AG4.44%289 068
MERCK AND COMPANY0.02%231 608
PFIZER3.39%224 187
NOVARTIS0.96%216 654
BRISTOL-MYERS SQUIBB COMPANY3.94%156 404
NOVO NORDISK AS6.96%144 481
AMGEN0.17%143 489
ASTRAZENECA3.02%133 679
ABBVIE INC.-0.61%130 136
SANOFI2.54%127 703
GLAXOSMITHKLINE3.32%118 266
BAYER AG3.69%82 204
ALLERGAN PLC0.79%63 252
TAKEDA PHARMACEUTICAL COMPANY LIMITED3.26%62 746
JIANGSU HENGRUI MEDICINE CO., LTD.3.59%57 784
CHUGAI PHARMACEUTICAL CO., LTD.6.75%53 051
DAIICHI SANKYO COMPANY, LIMITED2.66%43 185
ASTELLAS PHARMA INC.1.65%31 869
EISAI CO., LTD.3.29%21 719
Connections : Eli Lilly and Company